동물용 임신 검사 키트 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the animal pregnancy test kit market size is expected to grow from USD 61.83 million in 2025 to USD 64.63 million in 2026 and is forecast to reach USD 80.59 million by 2031 at 4.52% CAGR over 2026-2031.

This report is Segmented by Product Type (Pregnancy Test Cassette Kits, Pregnancy Test Strip/Dipstick Kits, ELISA-Based Kits), Animal Type (Companion Animals, Livestock), Sample Type (Serum/Plasma/Whole Blood, Milk, Urine), Distribution Channel (Veterinary Hospitals and Clinics, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Animal Pregnancy Test Kit Market Trends and Insights

Rising global pet ownership and "humanisation" of companion animals

Companion animals shifted from utility roles to family status, prompting owners to request human-grade diagnostics, including at-home pregnancy tests. Post-pandemic pet adoptions boosted total dog and cat populations, creating sustained demand for preventive kits that slot seamlessly into routine wellness schedules. Direct-to-consumer brands such as Bellylabs report high reorder rates, suggesting strong repeat-usage behaviour. Younger owners, comfortable with digital retail, prefer instant results, encouraging manufacturers to integrate mobile read-outs for clearer interpretation. Insurance policies increasingly reimburse reproductive testing, further normalising purchase frequency. Early detection also cuts emergency caesarean costs, reinforcing the economic case for regular screening.

Increasing herd-fertility economics for dairy and beef producers

Producers face tight feed margins and milk-price volatility, turning pregnancy confirmation into a cost-avoidance imperative. Extension studies show early culling of open cows can save thousands of USD per herd annually. Yet only one-third of U.S. beef operations deploy structured testing protocols, highlighting latent demand. Adoption accelerates where herd-management software automatically imports test results and triggers breeding alerts. Sexed-semen programs rely on quick confirmation to recycle high-value embryos, multiplying kit utilisation. Livestock bankers increasingly look for evidence of reproductive efficiency when extending credit, indirectly reinforcing kit usage across commercial operations.

High price point of advanced kits for smallholders

ELISA kits can cost up to five times more than basic lateral-flow strips, ranging from USD 15-50 per test, a significant outlay for small farms where average daily milk margins remain thin. The economics worsen when repeat testing is needed across long breeding seasons. Portable ultrasound systems present an even steeper hurdle, with initial investment exceeding USD 2,000 and further training costs. Without subsidised access, uptake among smallholders stays muted, limiting volume growth in emerging economies that house the bulk of global livestock.

Other drivers and restraints analyzed in the detailed report include:

1. Advances in rapid lateral-flow and ELISA diagnostic formats
2. Growing veterinary healthcare spend and insurance penetration
3. Sub-optimal sensitivity / specificity causing false results

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

The animal pregnancy test kit market size allocated to product types shows pregnancy test cassette kits retained 40.35% revenue share in 2025, but ELISA kits are projected to advance fastest at 6.28% CAGR. Livestock operators often reach for cassette formats because they are rugged, cost-efficient and offer herd-level economies. Conversely, equine breeders and companion-animal clinics pay premiums for ELISA's quantitative read-outs that support precise gestation staging, a capability lateral-flow strips lack. Hybrid microfluidic cartridges now blend rapid flow paths with ELISA capture chemistry, trimming assay time to under 15 minutes without sacrificing analytical power. As regulatory scrutiny strengthens, professional buyers favour formats that provide electronic audit trails, an emerging competitive differentiator.

While cassette kits remain ubiquitous on dairy farms, ELISA penetration rises wherever insurers reimburse test costs, tilting purchasing toward accuracy over price. The animal pregnancy test kit market sees manufacturers reposition strip-/dipstick products as mid-tier options that cater to mixed-practice clinics needing balanced cost and reliability. With nanomaterial-enhanced sensors entering late-stage validation, incumbent formats face future substitution risk, yet price elasticity in commodity-focused livestock segments suggests cassettes will defend baseline volumes through 2031.

Livestock held 68.62% of animal pregnancy test kit market share in 2025, largely due to the sheer scale of global cattle inventories. Companion-animal testing, however, clocks a 5.18% CAGR, reflecting owners' readiness to emulate human prenatal care protocols. Bovine testing enjoys entrenched protocols that tie pregnancy confirmation to feed rationing and genetic selection, making kits a predictable input expense. Swine producers now integrate whole-blood rapid assays into automated farrowing-management systems, enhancing litter planning accuracy.

In household pets, direct-to-consumer formats such as canine saliva and urine cassettes drive incremental volume with minimal veterinary intervention, mirroring human home pregnancy testing. Feline testing, historically limited to veterinary labs, benefits from newer progesterone chemistries that allow chair-side screening. These shifts anchor the animal pregnancy test kit industry's move toward diversified portfolios that cater simultaneously to farm bio-economics and boutique pet-care preferences.

Complete Report Scope:

• By Product Type
  • Pregnancy Test Cassette Kits
  • Pregnancy Test Strip/Dipstick Kits
  • ELISA-based Kits
• By Animal Type
  • Companion Animals
    • Dogs
    • Cats
    • Other Companion Animals
  • Livestock
    • Bovine
    • Equine
    • Swine
    • Small Ruminants
• By Sample Type
  • Serum / Plasma / Whole Blood
  • Milk
  • Urine
• By Distribution Channel
  • Veterinary Hospitals and Clinics
  • Retail Stores
  • E-commerce
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World

Geography Analysis

North America generated 36.22% of 2025 revenue, propelled by advanced veterinary infrastructure, insurance uptake and strict reproductive management norms. The United States spearheads adoption of AI-supported reference labs that report pregnancy status within hours, allowing same-day rebreeding decisions. Canada benefits from dairy supply-management incentives that reimburse pregnancy testing, while Mexico's export-oriented beef sector adopts kits to meet traceability mandates.

Asia-Pacific records a 6.05% CAGR, the fastest worldwide, as expanding commercial dairies in China and India turn to low-cost cassette kits to boost calving intervals. Urban pet ownership in Tokyo, Seoul and Shanghai fuels direct-to-consumer sales, especially urine-based formats. Veterinary associations in Thailand and Vietnam partner with manufacturers to subsidise training, narrowing the practitioner awareness gap. Price sensitivity remains pronounced in rural smallholder communities, yet cooperative bulk-buying schemes begin to dilute cost barriers.

Europe represents a mature but innovation-centric terrain. Dairy producers in France and Germany integrate milk pregnancy assays into robotic milking systems, securing consistent herd-level data streams. The European Food Safety Authority's push for validated diagnostic performance standards benefits ELISA suppliers with established clinical dossiers. Eastern European markets witness rapid catch-up growth as EU rural-development funds back reproductive efficiency projects. Collectively, these patterns affirm the animal pregnancy test kit market's regional mosaic, where domestic regulatory stance and economic structure dictate adoption velocity.

1. IDEXX
2. Neogen
3. BioNote Inc.
4. BioTracking
5. Zoetis
6. Fassisi
7. Randox Laboratories
8. Heska
9. Teco Diagnostics
10. Bellylabs Oy
11. Bioeasy Biotechnology
12. J & G Biotech Ltd
13. Agdia Inc.
14. Corteva Agriscience (Geneseek)
15. Arbor Assays
16. ScintiVet

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Global Pet Ownership and "Humanisation" of Companion Animals
  • 4.2.2 Increasing Herd-Fertility Economics for Dairy & Beef Producers
  • 4.2.3 Advances in Rapid Lateral-Flow & ELISA Diagnostic Formats
  • 4.2.4 Growing Veterinary Healthcare Spend & Insurance Penetration
  • 4.2.5 Nanomaterial-Enabled Ultra-Early Biosensor Kits
  • 4.2.6 Tele-Veterinary Platforms Bundling At-Home Pregnancy Testing
• 4.3 Market Restraints
  • 4.3.1 High Price Point of Advanced Kits for Smallholders
  • 4.3.2 Sub-Optimal Sensitivity / Specificity Causing False Results
  • 4.3.3 Low Practitioner Awareness in Emerging Markets
  • 4.3.4 Regulatory Grey-Zones for DTC Animal Diagnostics
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers/Consumers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitute Products
  • 4.7.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value)

• 5.1 By Product Type
  • 5.1.1 Pregnancy Test Cassette Kits
  • 5.1.2 Pregnancy Test Strip/Dipstick Kits
  • 5.1.3 ELISA-based Kits
• 5.2 By Animal Type
  • 5.2.1 Companion Animals
    • 5.2.1.1 Dogs
    • 5.2.1.2 Cats
    • 5.2.1.3 Other Companion Animals
  • 5.2.2 Livestock
    • 5.2.2.1 Bovine
    • 5.2.2.2 Equine
    • 5.2.2.3 Swine
    • 5.2.2.4 Small Ruminants
• 5.3 By Sample Type
  • 5.3.1 Serum / Plasma / Whole Blood
  • 5.3.2 Milk
  • 5.3.3 Urine
• 5.4 By Distribution Channel
  • 5.4.1 Veterinary Hospitals and Clinics
  • 5.4.2 Retail Stores
  • 5.4.3 E-commerce
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Rest of the World

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 IDEXX Laboratories
  • 6.3.2 Neogen Corporation
  • 6.3.3 BioNote Inc.
  • 6.3.4 BioTracking
  • 6.3.5 Zoetis Inc.
  • 6.3.6 Fassisi GmbH
  • 6.3.7 Randox Laboratories Ltd
  • 6.3.8 Heska Corporation
  • 6.3.9 Teco Diagnostics
  • 6.3.10 Bellylabs Oy
  • 6.3.11 Bioeasy Biotechnology
  • 6.3.12 J & G Biotech Ltd
  • 6.3.13 Agdia Inc.
  • 6.3.14 Corteva Agriscience (Geneseek)
  • 6.3.15 Arbor Assays
  • 6.3.16 ScintiVet

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment